Abstract
Two young females who had chronic active hepatitis associated with Graves' disease are reported. Both patients had high circulating levels of immunoglobulin G and 1 had a monoclonal gammopathy which disappeared with steroid therapy. The other patient had exophthalmos and high circulating levels of long acting thyroid stimulator (LATS) which were paralleled by very high antibody titers to respiratory syncytial virus, herpes simplex, and echovirus 9. Both patients showed positive smooth muscle antibody and negative Australia antigen. In 1 case LATS and smooth muscle antibodies were found in the pleural fluid. Both patients had a wide variety of abnormal antibodies.
Similar content being viewed by others
References
Waldenstrom J: Leber Blutproteine und Nahrung-sieweiss Staffwecks Krk Sonderband XV. Tagung Bad Kissingen 8, 1950
Kunkel HG, Ahrens EH Jr, Eisenmenger WJ, et al: Extreme hypergammaglobulinaemia in young women with liver disease of unknown etiology. J Clin Invest 30:654, 1951 (Abstr)
Saint EG, King WE, Joska RA, Finckh ES: The course of infectious hepatitis with special reference to prognosis in the chronic stage. Aust Ann Med 2:113–127, 1953
McKenzie JM: Hormonal factors in the pathogenesis of Graves' disease. Physiol Rev 48:252–310, 1968
Kriss JP: The long-acting thyroid stimulator. Calif Med 109:202–213, 1968
Silva H, Hall EW, Hill KR: Renal involvement in active ‘juvenile’ cirrhosis. J Clin Path 18:157–163, 1965
Hart IR: The lipolytic effect of LATS-IgG and Graves' disease sera. Abstract 67, The Sixth International Thyroid Conference, Vienna, 1970
McKay IR, Weiden S, Hasker J: Auto-immune hepatitis. Ann NY Acad Sci 124:767–780, 1965
Geall MG, Schoenfield LJ, Summerskill WHJ: Classification and treatment of chronic active liver disease. Gastroenterology 55:724–729, 1970
Soloway RD, Baggenstoss AH, Elveback LR, Schoenfield LJ, Stubbs BL, Summerskill, WHJ: Are azathioprine and prednisone effective in the early treatment of chronic active liver disease (CALD)? Gastroent Abstract 58:995, 1970
DeGroot J, Desmet VJ, Gedigk P, Korb G, Popper H, Poulsen H, Scheuer PJ, Schmid M, Thaler H, Uehlinger E: A classification of chronic hepatitis. Lancet 2:626–628, 1968
Becker MD, Scheuer PJ, Baptista A, Sherlock S: Prognosis of chronic persistent hepatitis. Lancet 1:53–57, 1970
Levine RA, Ranek L: Asymptomatic chronic hepatitis. Gastroenterology 58:371–378, 1970
MacLachlan MJ, Rodnan GP, Cooper WM, Fennell RH: Chronic active (“lupoid”) hepatitis. Ann Intern Med 62:425–442, 1965
Mistilis SP, Blackburn CRB: Chronic active hepatitis. Am J Med 48:484–494, 1970
Sattler H, quoted in McKenzie JM: Physiol Rev 48:252, 1968
Gunn A, Michie W, Irvine WJ: The thymus in thyroid disease. Lancet 2:776–778, 1964
Irvine WJ, Sumerling MD: Radiological assessment of the thymus in thyroid and other diseases. Lancet 1:996–999, 1965
Tudhope GR: The Thyroid and the Blood. London, William Heinemann, Ltd, 1969
Simpson JA: Immunological disturbances in myasthenia gravis with a report of Hashimoto's disease developing after thymectomy. J Neurol Neurosurg Psychiatry 27:485–492, 1964
Papadopoulos C, Rouben J, Maher E: Lupus erythematosus and hyperthyroidism. Am J Dis Child 118:621–624, 1969
Marshall JS, Weisberger AS, Levy RP, Breckenridge RT: Coexistent idiopathic thrombocytopenic purpura and hyperthyroidism. Ann Intern Med 67:411–414, 1967
Mason AMS, Golding PL: Renal tubular acidosis and autoimmune thyroid disease. Lancet 2:1104–1107, 1970
Anderson JR, Gray KG, Middleton DG, Young JA: Autoimmunity and thyrotoxicosis. Br Med J 2:1630–1632, 1964
Howel-Evans AW, Woodrow JC, McDougal CDM, Chew AR, Winston-Evans R: Antibodies in the families of thyrotoxic patients. Lancet 1:636–641, 1967
Carneiro L, Dorrington KJ, Munro DS: Recovery of the long-acting thyroid stimulator from serum of patients with thyrotoxicosis by concentration of immunoglobulin. Clin Sci 31:215–221, 1966
Hart IR, McKenzie JM: Comparison of the effects of thyrotropin and the long-acting thyroid stimulator on guinea pig adipose tissue. Endocrinology 88:26–30, 1971
Zawadzki ZA, Edwards GA: Dysimmunoglobulinaemia associated with hepatobiliary disorder. Am J Med 48:196–202, 1970
Paraneto F, Rubin E, Popper H: Local formation of gammaglobulin in the diseased liver and its relation to hepatic necrosis. Lab Invest 11:150–158, 1962
Protell RL, Soloway RD, Martin WJ, Schoenfield LJ, Summerskill WHJ: Anti-salmonella agglutinins in chronic active liver disease. Lancet 2:330–331, 1971
Popper H, Paraneto F, Schaffner F: Immune processes in pathogenesis of liver disease. Ann NY Acad Sci 124:781–799, 1965
Dudley FJ, Fox RA, Sherlock S: Relationship of hepatitis associated antigen (HAA) to acute and chronic liver injury. Lancet 2:1–3, 1971
Potz LD: Variable mechanism for low serum complement in liver disease. Lancet 2:1033–4, 1971
Reynolds TB, Peters RL, Yamada S: Chronic active and lupoid hepatitis caused by a laxative, oxyphenisatin. N Engl J Med 285:813–820, 1971
Schaffner F, Klion FM: Chronic hepatitis. Annu Rev Med 19:25–38, 1968
Doniach D: The concept of “autoallergic” hepatitis. Proc Roy Soc Med 63:527–531, 1970
Good RA, Page AR: Fatal complications of viral hepatitis in two patients with agammaglobulinaemia. Am J Med 29:804–810, 1960
Pitt-Rivers R, Trotter WR: Hyperthyroidism, The Thyroid Gland. Volume 2. London, Butterworth & Co, Ltd, 1964, p 152
Author information
Authors and Affiliations
Additional information
Dr. Ian Hart was supported in part by M.R.C. of Canada Grant MA-3925.
Rights and permissions
About this article
Cite this article
Thompson, W.G., Hart, I.R. Chronic active hepatitis and Graves' disease. Digest Dis Sci 18, 111–119 (1973). https://doi.org/10.1007/BF01073154
Issue Date:
DOI: https://doi.org/10.1007/BF01073154